VivoPower PLC (VIVO)vsZepp Health Corp (ZEPP)
VIVO
VivoPower PLC
$2.91
-8.78%
TECHNOLOGY · Cap: $53.56M
ZEPP
Zepp Health Corp
$18.01
-2.28%
TECHNOLOGY · Cap: $270.28M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 424321% more annual revenue ($258.90M vs $61,000). VIVO leads profitability with a 0.0% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 38/100 (F).
VIVO
Avoid26
out of 100
Grade: F
ZEPP
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for VIVO.
Margin of Safety
+48.8%
Fair Value
$46.82
Current Price
$18.01
$28.81 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 47.6% year-over-year
Reasonable price relative to book value
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
0.0% margin — thin
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : VIVO
The strongest argument for VIVO centers on Revenue Growth, Price/Book. Revenue growth of 47.6% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : VIVO
The primary concerns for VIVO are EPS Growth, Market Cap, Return on Equity.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
VIVO is growing revenue faster at 47.6% — sustainability is the question.
VIVO generates stronger free cash flow (-3M), providing more financial flexibility.
Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (38/100 vs 26/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
VivoPower PLC
TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA
Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - INFRASTRUCTURE Stocks
Want to dig deeper into these stocks?